Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Northrop Grumman Corporation (NOC) Price & Performance

AbCellera Biologics IncTrade
Northrop Grumman CorporationTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Northrop Grumman Corporation — how do they compare? AbCellera Biologics Inc trades at $8.95 (market cap $2.99B), while Northrop Grumman Corporation trades at $574.85 (market cap $81.78B). The key difference: Northrop Grumman Corporation is far larger — about 27.4× AbCellera Biologics Inc's market cap, and Northrop Grumman Corporation pays a 1.63% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLNOC
Market Cap
$2.99B$81.78B
Sector
HealthIndustrials
52-Week High
$9.76$768.02
52-Week Low
$2.78$496.02
Enterprise Value
$2.58B$95.77B
Dividend Yield
1.63%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC